CAYLA has a total of 25 patent applications. Its first patent ever was published in 1989. It filed its patents most often in United States, EPO (European Patent Office) and France. Its main competitors in its focus markets biotechnology, pharmaceuticals and foods and drinks are SLBIGEN INC, OCTAGENE GMBH and TEMASEK LIFE SCIENCES LABORATORY LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | EPO (European Patent Office) | 5 | |
#3 | France | 5 | |
#4 | WIPO (World Intellectual Property Organization) | 5 | |
#5 | Australia | 2 | |
#6 | Canada | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Foods and drinks | |
#4 | Environmental technology | |
#5 | Organic fine chemistry | |
#6 | Basic materials chemistry | |
#7 | Chemical engineering | |
#8 | Machines |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Enzymes | |
#5 | Climate change adaptation technologies | |
#6 | Soaps | |
#7 | Textile treatments | |
#8 | Heterocyclic compounds | |
#9 | Microorganisms | |
#10 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Tiraby Gerard | 15 |
#2 | Drocourt Daniel | 13 |
#3 | Reynes Jean-Paul | 9 |
#4 | Tiraby Michele | 4 |
#5 | Vernejoul Fabienne | 4 |
#6 | Durand Henri Paul | 4 |
#7 | Cazaux Christophe | 4 |
#8 | Perouzel Eric | 4 |
#9 | Armau Elise | 3 |
#10 | Calmels Thierry | 3 |
Publication | Filing date | Title |
---|---|---|
US2014242108A1 | Conjugated TLR7 and/or TLR8 and TLR2 polycationic agonists | |
US2011008894A1 | Lyophilized plasmid/dna transfection reagent carrier complex | |
FR2821855A1 | SYNTHETIC GENES AND BACTERIAL PLASMIDS WITHOUT GIC | |
EP0974645A1 | Procedure to prepare, by the use of microwaves, sterile liquid or solid culture media, for the recognition and identification of recombinant microorganisms | |
US5856153A | Suicide genes and new associations of pyrimidine nucleobase and nucleoside analogs with new suicide genes for gene therapy of acquired diseases | |
FR2665363A1 | Pharmaceutical composition comprising bleomycin (s) and bleomycin-inactive protein (s). | |
FR2649120A1 | NOVEL STRAIN AND FILAMENTOUS MUSHROOM MUTANTS, PROCESS FOR THE PRODUCTION OF RECOMBINANT PROTEINS USING THE SAME AND STRAINS AND PROTEINS OBTAINED THEREBY | |
FR2649102A1 | Novel herbicide compounds, cl22t and derivatives thereof, process for the preparation thereof, herbicide compositions containing them, and process for the treatment of weeding | |
FR2641555A1 | Process for heterogeneous washing of dyed cotton-based articles using cellulases in an aqueous medium |